Metabolic syndrome increases mortality in heart failure
Leonardo Tamariz1, Benjamin Hassan, Ana Palacio
1Department of Medicine, Miller School of Medicine at the University of Miami, Miami, Florida 33136, USA. ltamariz@med.miami.edu
Clinical Cardiology
|July 2, 2009
Summary
Metabolic syndrome (MetS) significantly increases mortality risk in heart failure (HF) patients. Early identification and management of MetS are crucial for improving outcomes in this vulnerable population.
Area of Science:
- Cardiology
- Metabolic Diseases
- Public Health
Background:
- Metabolic syndrome (MetS) is a known risk factor for diabetes, cardiovascular disease, and heart failure (HF).
- The impact of MetS on individuals already diagnosed with HF remains under-researched.
- Understanding this relationship is critical for comprehensive patient care.
Purpose of the Study:
- To investigate the prevalence of MetS in indigent heart failure patients.
- To determine the association between MetS and mortality risk in this population.
- To highlight the clinical implications for managing HF patients with MetS.
Main Methods:
- Analysis of 865 indigent HF patients in a disease management program.
- MetS classification based on National Cholesterol Education Program criteria (≥3 criteria).
- Mortality data obtained from the Social Security Death Index; relative hazard (RH) calculated.
Main Results:
- MetS prevalence was 40% in the study cohort.
- Patients with MetS had a higher mortality rate (24% vs. 16%) after 2.6 years.
- MetS was associated with a 1.5-fold increased risk of death (RH: 1.5; 95% CI: 1.1-2.1) after adjustments.
Conclusions:
- MetS is highly prevalent among indigent heart failure patients.
- The presence of MetS significantly elevates the risk of mortality in HF patients.
- Clinicians must prioritize addressing the MetS epidemic within the HF patient population.
Related Concept Videos
Heart Failure I: Introduction
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
Pathophysiology of Heart Failure
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Heart Failure III: Clinical Manifestations
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
Heart Failure V: Medical Management
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
